Synthesis and in Vitro Evaluation of Bone-Seeking Superparamagnetic Iron Oxide Nanoparticles as Contrast Agents for Imaging Bone Metabolic Activity

详细信息    查看全文

• 作者：Arash Panahifar ; Morteza Mahmoudi ; Michael R. Doschak
• 刊名：ACS Applied Materials & Interfaces
• 出版年：2013
• 出版时间：June 12, 2013
• 年：2013
• 卷：5
• 期：11
• 页码：5219-5226
• 全文大小：457K
• 年卷期：v.5,no.11(June 12, 2013)
• ISSN：1944-8252

文摘

In this article, we report the synthesis and in vitro evaluation of a new class of nonionizing bone-targeting contrast agents based on bisphosphonate-conjugated superparamagnetic iron oxide nanoparticles (SPIONs), for use in imaging of bone turnover with magnetic resonance imaging (MRI). Similar to bone-targeting ^99mTechnetium medronate, our novel contrast agent uses bisphosphonates to impart bone-seeking properties, but replaces the former radioisotope with nonionizing SPIONs which enables their subsequent detection using MRI. Our reported method is relatively simple, quick and cost-effective and results in BP-SPIONs with a final nanoparticle size of 17 nm under electron microscopy technique (i.e., TEM). In-vitro binding studies of our novel bone tracer have shown selective binding affinity (around 65%) for hydroxyapatite, the principal mineral of bone. Bone-targeting SPIONs offer the potential for use as nonionizing MRI contrast agents capable of imaging dynamic bone turnover, for use in the diagnosis and monitoring of metabolic bone diseases and related bone pathology.

Keywords:

bisphosphonate; superparamagnetic iron oxide nanoparticles; diagnosis; MRI; contrast agent; selective binding; bone; osteoarthritis